chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: excruciation pain from shoulder to wrist; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (excruciation pain from shoulder to wrist) and FATIGUE (fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (excruciation pain from shoulder to wrist) and FATIGUE (fatigue). On 06-Apr-2021, PAIN IN EXTREMITY (excruciation pain from shoulder to wrist) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Erythema, Pain in extremity, Tenderness, Tonsillitis
Clinical narrative: bitterness in mouth; tonsils is very white; arm is reddish tender; Arm is painful; Arm is reddish; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (bitterness in mouth), TONSILLITIS (tonsils is very white), TENDERNESS (arm is reddish tender ), PAIN IN EXTREMITY (Arm is painful) and ERYTHEMA (Arm is reddish ) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01AB21A and 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PANTOPRAZOLE, LOSARTAN and DEXLANSOPRAZOLE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced DYSGEUSIA (bitterness in mouth), TONSILLITIS (tonsils is very white), TENDERNESS (arm is reddish tender ), PAIN IN EXTREMITY (Arm is painful) and ERYTHEMA (Arm is reddish ). At the time of the report, DYSGEUSIA (bitterness in mouth), TONSILLITIS (tonsils is very white), TENDERNESS (arm is reddish tender ), PAIN IN EXTREMITY (Arm is painful) and ERYTHEMA (Arm is reddish ) outcome was unknown. Not Provided          Treatment details included cold compress. Action taken with mRNA-1273 in response to events were not applicable.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: reports arm pain; red, hot and swollen arm; red, hot and swollen arm; red, hot and swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (reports arm pain), ERYTHEMA (red, hot and swollen arm), FEELING HOT (red, hot and swollen arm) and PERIPHERAL SWELLING (red, hot and swollen arm) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (reports arm pain), ERYTHEMA (red, hot and swollen arm), FEELING HOT (red, hot and swollen arm) and PERIPHERAL SWELLING (red, hot and swollen arm). At the time of the report, PAIN IN EXTREMITY (reports arm pain), ERYTHEMA (red, hot and swollen arm), FEELING HOT (red, hot and swollen arm) and PERIPHERAL SWELLING (red, hot and swollen arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information included Moisturizing cream.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Electrocardiogram, Fatigue, Heart rate, Hyperhidrosis
Clinical narrative: tiredness/fatigue; went pale; numbness in arms; sweating; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALLOR (went pale), HYPOAESTHESIA (numbness in arms), HYPERHIDROSIS (sweating), CHILLS (chills) and FATIGUE (tiredness/fatigue) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (preservatives), Contrast media allergy, Lactose intolerance and Gluten intolerance.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PALLOR (went pale). 31-Mar-2021, the patient experienced HYPOAESTHESIA (numbness in arms), HYPERHIDROSIS (sweating) and CHILLS (chills). On 06-Apr-2021, the patient experienced FATIGUE (tiredness/fatigue). On 31-Mar-2021, PALLOR (went pale), HYPOAESTHESIA (numbness in arms), HYPERHIDROSIS (sweating) and CHILLS (chills) had resolved. At the time of the report, FATIGUE (tiredness/fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Electrocardiogram: abnormal (abnormal) EKG abnormality persisted for 3 hours from her time of arrival to the hospital. On 31-Mar-2021, Heart rate: decreased (Low) decreased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details were not provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pallor
Clinical narrative: tiredness/fatigue; went pale; numbness in arms; sweating; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALLOR (went pale), HYPOAESTHESIA (numbness in arms), HYPERHIDROSIS (sweating), CHILLS (chills) and FATIGUE (tiredness/fatigue) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (preservatives), Contrast media allergy, Lactose intolerance and Gluten intolerance.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PALLOR (went pale). 31-Mar-2021, the patient experienced HYPOAESTHESIA (numbness in arms), HYPERHIDROSIS (sweating) and CHILLS (chills). On 06-Apr-2021, the patient experienced FATIGUE (tiredness/fatigue). On 31-Mar-2021, PALLOR (went pale), HYPOAESTHESIA (numbness in arms), HYPERHIDROSIS (sweating) and CHILLS (chills) had resolved. At the time of the report, FATIGUE (tiredness/fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Electrocardiogram: abnormal (abnormal) EKG abnormality persisted for 3 hours from her time of arrival to the hospital. On 31-Mar-2021, Heart rate: decreased (Low) decreased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details were not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Losing use of left arm; arm is still painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is still painful) and INJECTED LIMB MOBILITY DECREASED (Losing use of left arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm is still painful). On 13-Feb-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (Losing use of left arm). At the time of the report, PAIN IN EXTREMITY (arm is still painful) and INJECTED LIMB MOBILITY DECREASED (Losing use of left arm) outcome was unknown.            Treatment details included ibuprofen and steroids. Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: pain at all at the injection site; fever of 101; severe headache; nausea; tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), PYREXIA (fever of 101), HEADACHE (severe headache), NAUSEA (nausea) and VACCINATION SITE PAIN (pain at all at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LANSOPRAZOLE for Heartburn-like dyspepsia.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 30-Mar-2021, the patient experienced FATIGUE (tired). On 31-Mar-2021, the patient experienced PYREXIA (fever of 101), HEADACHE (severe headache) and NAUSEA (nausea). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at all at the injection site). On 02-Apr-2021, HEADACHE (severe headache) had resolved. At the time of the report, FATIGUE (tired), PYREXIA (fever of 101), NAUSEA (nausea) and VACCINATION SITE PAIN (pain at all at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       She was scheduled for 2nd dose on 29Apr2021 and gave the consent for follow up by safety.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Influenza A virus test, Malaise
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of malaise (didn't feel well this weekend) and influenza (twice tested positive for type A flu) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 003A21A) for COVID-19 immunization. No medical history reported. On Mar 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 24, 2021, patient experienced influenza (twice tested positive for type A flu). On an unknown date, patient experienced malaise (didn't feel well this weekend). The patient treated with Z-Pak (azithromycin), at an unspecified dose and frequency. At the time of the report, malaise (didn't feel well this weekend) and influenza (twice tested positive for type A flu) outcome: unknown/not provided. Diagnostic results: On Mar 24, 2021, influenza A virus test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications provided. Most recent follow-up information incorporated: On May 20, 2021: Additional information received on May 20, 2021 contained no new information.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: two bouts of diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (two bouts of diarrhea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 06-Apr-2021, the patient experienced DIARRHOEA (two bouts of diarrhea). At the time of the report, DIARRHOEA (two bouts of diarrhea) outcome was unknown. Not Provided          no concomitant medications reported. no treatment details reported.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Feeling abnormal, Headache, Illness
Clinical narrative: throwing up clear liquid; legs hurts- muscle and joint pain; symptoms felt like a flu; tired/exhausted/ didn't look good; feel bad; trouble sleeping/ no sleep yet; have anxieties; feel sick; arm from injection site hurt so bad and swollen; arm from injection site hurt so bad and swollen; gland underarm of injection site is swollen; stabbing headaches; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen) and VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A. and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ALPRAZOLAM (XANAX) for Anxiety, MONTELUKAST SODIUM (SINGULAIR) for Asthma, TRAZODONE for Sleep disorder.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen), VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen), LYMPHADENOPATHY (gland underarm of injection site is swollen), HEADACHE (stabbing headaches), INFLUENZA LIKE ILLNESS (symptoms felt like a flu), FATIGUE (tired/exhausted/ didn't look good) and FEELING ABNORMAL (feel bad). On an unknown date, the patient experienced VOMITING (throwing up clear liquid) and MYALGIA (legs hurts- muscle and joint pain). The patient was treated with PARACETAMOL (TYLENOL) on 05-Apr-2021 at an unspecified dose and frequency. At the time of the report, SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen), VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen), LYMPHADENOPATHY (gland underarm of injection site is swollen), HEADACHE (stabbing headaches), VOMITING (throwing up clear liquid), MYALGIA (legs hurts- muscle and joint pain), INFLUENZA LIKE ILLNESS (symptoms felt like a flu), FATIGUE (tired/exhausted/ didn't look good) and FEELING ABNORMAL (feel bad) outcome was unknown.            Patient took Xanax on 6Apr2021 for her anxiety and trouble sleeping. She also took Tylenol last night (5Apr2021) 10 hours after her 2nd dose of vaccine and put some ice on her arm where she had the injection.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymphadenopathy, Myalgia, Sleep disorder, Vaccination site pain
Clinical narrative: throwing up clear liquid; legs hurts- muscle and joint pain; symptoms felt like a flu; tired/exhausted/ didn't look good; feel bad; trouble sleeping/ no sleep yet; have anxieties; feel sick; arm from injection site hurt so bad and swollen; arm from injection site hurt so bad and swollen; gland underarm of injection site is swollen; stabbing headaches; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen) and VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A. and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ALPRAZOLAM (XANAX) for Anxiety, MONTELUKAST SODIUM (SINGULAIR) for Asthma, TRAZODONE for Sleep disorder.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen), VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen), LYMPHADENOPATHY (gland underarm of injection site is swollen), HEADACHE (stabbing headaches), INFLUENZA LIKE ILLNESS (symptoms felt like a flu), FATIGUE (tired/exhausted/ didn't look good) and FEELING ABNORMAL (feel bad). On an unknown date, the patient experienced VOMITING (throwing up clear liquid) and MYALGIA (legs hurts- muscle and joint pain). The patient was treated with PARACETAMOL (TYLENOL) on 05-Apr-2021 at an unspecified dose and frequency. At the time of the report, SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen), VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen), LYMPHADENOPATHY (gland underarm of injection site is swollen), HEADACHE (stabbing headaches), VOMITING (throwing up clear liquid), MYALGIA (legs hurts- muscle and joint pain), INFLUENZA LIKE ILLNESS (symptoms felt like a flu), FATIGUE (tired/exhausted/ didn't look good) and FEELING ABNORMAL (feel bad) outcome was unknown.            Patient took Xanax on 6Apr2021 for her anxiety and trouble sleeping. She also took Tylenol last night (5Apr2021) 10 hours after her 2nd dose of vaccine and put some ice on her arm where she had the injection.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: throwing up clear liquid; legs hurts- muscle and joint pain; symptoms felt like a flu; tired/exhausted/ didn't look good; feel bad; trouble sleeping/ no sleep yet; have anxieties; feel sick; arm from injection site hurt so bad and swollen; arm from injection site hurt so bad and swollen; gland underarm of injection site is swollen; stabbing headaches; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen) and VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A. and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ALPRAZOLAM (XANAX) for Anxiety, MONTELUKAST SODIUM (SINGULAIR) for Asthma, TRAZODONE for Sleep disorder.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen), VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen), LYMPHADENOPATHY (gland underarm of injection site is swollen), HEADACHE (stabbing headaches), INFLUENZA LIKE ILLNESS (symptoms felt like a flu), FATIGUE (tired/exhausted/ didn't look good) and FEELING ABNORMAL (feel bad). On an unknown date, the patient experienced VOMITING (throwing up clear liquid) and MYALGIA (legs hurts- muscle and joint pain). The patient was treated with PARACETAMOL (TYLENOL) on 05-Apr-2021 at an unspecified dose and frequency. At the time of the report, SLEEP DISORDER (trouble sleeping/ no sleep yet), ANXIETY (have anxieties), ILLNESS (feel sick), VACCINATION SITE PAIN (arm from injection site hurt so bad and swollen), VACCINATION SITE SWELLING (arm from injection site hurt so bad and swollen), LYMPHADENOPATHY (gland underarm of injection site is swollen), HEADACHE (stabbing headaches), VOMITING (throwing up clear liquid), MYALGIA (legs hurts- muscle and joint pain), INFLUENZA LIKE ILLNESS (symptoms felt like a flu), FATIGUE (tired/exhausted/ didn't look good) and FEELING ABNORMAL (feel bad) outcome was unknown.            Patient took Xanax on 6Apr2021 for her anxiety and trouble sleeping. She also took Tylenol last night (5Apr2021) 10 hours after her 2nd dose of vaccine and put some ice on her arm where she had the injection.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: a whooshing sound on my hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (a whooshing sound on my hot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (a whooshing sound on my hot). At the time of the report, FEELING ABNORMAL (a whooshing sound on my hot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication information was provided  No treatment product information was provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Drainage, Headache, Oropharyngeal pain
Clinical narrative: sore throat; drainage; headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), DRAINAGE (drainage) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), DRAINAGE (drainage) and HEADACHE (headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat), DRAINAGE (drainage) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: she missed her second Moderna dose scheduled for 8Feb2021 due to her COVID-19; positive COVID-19 diagnosis; cough; Fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (positive COVID-19 diagnosis), PRODUCT DOSE OMISSION ISSUE (she missed her second Moderna dose scheduled for 8Feb2021 due to her COVID-19), COUGH (cough) and FATIGUE (Fatigue) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (positive COVID-19 diagnosis). On 08-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (she missed her second Moderna dose scheduled for 8Feb2021 due to her COVID-19). On an unknown date, the patient experienced COUGH (cough) and FATIGUE (Fatigue). The patient was treated with AZITHROMYCIN (ZITHROMAX Z-PACK) (oral) for SARS-CoV-2 infection, at a dose of 5 day dosage; METHYLPREDNISOLONE (MEDROL DOSEPAK) (oral) for SARS-CoV-2 infection, at a dose of 5 days dosage; ASCORBIC ACID (VIT C) (oral) for SARS-CoV-2 infection, at a dose of 1 g once a day; ZINC (oral) for SARS-CoV-2 infection, at a dose of 100 mg once a day and MONOCLONAL ANTIBODY 17-1A (intravenous) for SARS-CoV-2 infection, at an unspecified dose and frequency. On 08-Feb-2021, PRODUCT DOSE OMISSION ISSUE (she missed her second Moderna dose scheduled for 8Feb2021 due to her COVID-19) had resolved. At the time of the report, COVID-19 (positive COVID-19 diagnosis), COUGH (cough) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test: positive (Positive) Nasopharyngeal source.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. Patient did not experience any covid-19 related complications or dysfunctions.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: received  Reporter email address updated. On 27-Jun-2021:  On 28-Jun-2021: Significant follow up- patient medical history, additional symptom and treatment drug updated
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Gastrointestinal disorder
Clinical narrative: he experienced GI issues 5 days after receiving 1st dose; He felt light headed; his BP was high (147/92)/His BP was around 170/95; This spontaneous case was reported by a pharmacist and describes the occurrence of GASTROINTESTINAL DISORDER (he experienced GI issues 5 days after receiving 1st dose), DIZZINESS (He felt light headed) and BLOOD PRESSURE INCREASED (his BP was high (147/92)/His BP was around 170/95) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concomitant products included MACROGOL 3350 (MIRALAX) and FAMOTIDINE (PEPCID AC) for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 02-Apr-2021, the patient experienced GASTROINTESTINAL DISORDER (he experienced GI issues 5 days after receiving 1st dose), DIZZINESS (He felt light headed) and BLOOD PRESSURE INCREASED (his BP was high (147/92)/His BP was around 170/95). At the time of the report, GASTROINTESTINAL DISORDER (he experienced GI issues 5 days after receiving 1st dose), DIZZINESS (He felt light headed) and BLOOD PRESSURE INCREASED (his BP was high (147/92)/His BP was around 170/95) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Blood pressure measurement (110/70-120/80 mmHg): 147/92 mmHg (High) patients blood pressure is elevated than normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   CT scan, EKG, blood works normal.  Treatment information not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site inflammation, Vaccination site rash, Vaccination site reaction
Clinical narrative: COVID arm; Injection site hard; Injection site  area was red.; INJECTION SITE RASH; Injection site  inflamed / area was red.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Injection site  inflamed / area was red.), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE INDURATION (Injection site hard), VACCINATION SITE ERYTHEMA (Injection site  area was red.) and VACCINATION SITE RASH (INJECTION SITE RASH) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21 and 031B21) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (Injection site  inflamed / area was red.), VACCINATION SITE INDURATION (Injection site hard), VACCINATION SITE ERYTHEMA (Injection site  area was red.) and VACCINATION SITE RASH (INJECTION SITE RASH). On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm). On 21-Mar-2021, VACCINATION SITE INFLAMMATION (Injection site  inflamed / area was red.) and VACCINATION SITE INDURATION (Injection site hard) had resolved, VACCINATION SITE ERYTHEMA (Injection site  area was red.) outcome was unknown. On 23-Mar-2021, VACCINATION SITE RASH (INJECTION SITE RASH) had resolved. At the time of the report, VACCINATION SITE REACTION (COVID arm) outcome was unknown. Not Provided          Concomitant medication use was unknown Treatment information was unknown   This case was linked to MOD-2021-068732 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: A new event rash was added. All event outcomes were changed to Resolved. The Batch number of doses was updated. On 16-Jul-2021: Event Covid Arm  added having outcome unknown
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema
Clinical narrative: swelling in the arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in the arm) and VACCINATION SITE ERYTHEMA (redness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025821A and 010421A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer since an unknown date.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in the arm) and VACCINATION SITE ERYTHEMA (redness). At the time of the report, PERIPHERAL SWELLING (swelling in the arm) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.            Concomitant information were not reported. Treatment information were not reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain in extremity, Paraesthesia
Clinical narrative: dizziness; headache with tingling sensation; headache with tingling sensation; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), DIZZINESS (dizziness), PARAESTHESIA (headache with tingling sensation) and HEADACHE (headache with tingling sensation) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo since February 2021. Concomitant products included DULOXETINE and GABAPENTIN for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm). On 04-Apr-2021, the patient experienced DIZZINESS (dizziness), PARAESTHESIA (headache with tingling sensation) and HEADACHE (headache with tingling sensation). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 02-Apr-2021, PAIN IN EXTREMITY (pain in arm) had resolved. At the time of the report, DIZZINESS (dizziness), PARAESTHESIA (headache with tingling sensation) and HEADACHE (headache with tingling sensation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site discomfort
Clinical narrative: Pain in arm; chip in the vaccine moving around in my arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE DISCOMFORT (chip in the vaccine moving around in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE DISCOMFORT (chip in the vaccine moving around in my arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE DISCOMFORT (chip in the vaccine moving around in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.    Reporter did not allow further contact
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Feeling abnormal, Pruritus, Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (developed rash underneath the left arm), PRURITUS (It started as localized area of itching), BURNING SENSATION (burning), FEELING ABNORMAL (very moist and was feeling very uncomfortable) and ERYTHEMA (finally the area turned bright red in color) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse effect. Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) and GLIPIZIDE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (developed rash underneath the left arm), PRURITUS (It started as localized area of itching), BURNING SENSATION (burning), FEELING ABNORMAL (very moist and was feeling very uncomfortable), ERYTHEMA (finally the area turned bright red in color) and RASH (noticed its getting bigger and bigger and moving down the arm.). At the time of the report, RASH (developed rash underneath the left arm), PRURITUS (It started as localized area of itching), BURNING SENSATION (burning), FEELING ABNORMAL (very moist and was feeling very uncomfortable), ERYTHEMA (finally the area turned bright red in color) and RASH (noticed its getting bigger and bigger and moving down the arm.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash, Vaccination site warmth
Clinical narrative: Rash is flat, pink and warm to the touch; Rash spreading horizontally on right arm; A rash pink in color quickly went to spreading; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Rash is flat, pink and warm to the touch), RASH (Rash spreading horizontally on right arm) and VACCINATION SITE RASH (A rash pink in color quickly went to spreading) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031b21a and 029a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021 at 3:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021 at 3:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Rash is flat, pink and warm to the touch), RASH (Rash spreading horizontally on right arm) and VACCINATION SITE RASH (A rash pink in color quickly went to spreading). At the time of the report, VACCINATION SITE WARMTH (Rash is flat, pink and warm to the touch), RASH (Rash spreading horizontally on right arm) and VACCINATION SITE RASH (A rash pink in color quickly went to spreading) had resolved.            No concomitant medication were provided. No treatment medication were provided.     This case was linked to MOD-2021-068722 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received and added patient height, weight and race. Outcome of the events were updated. On 16-Jul-2021: Follow up received and contain no new information.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Fatigue, Headache, Myalgia
Clinical narrative: Burning chest pain/sharp chest pain; Sharp back pain; Body pain; Headache; Body pain; Fatigue/tiredness; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Burning chest pain/sharp chest pain), BACK PAIN (Sharp back pain), PAIN (Body pain), HEADACHE (Headache) and MYALGIA (Body pain) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Colitis. Concomitant products included MESALAZINE (LIALDA) for Colitis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), PROBIOTICS NOS, FISH OIL, INFLIXIMAB (REMICADE) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced CHEST PAIN (Burning chest pain/sharp chest pain), BACK PAIN (Sharp back pain), PAIN (Body pain), HEADACHE (Headache), MYALGIA (Body pain) and FATIGUE (Fatigue/tiredness). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at a dose of 1 dosage form and BISMUTH SUBSALICYLATE (PEPTO-BISMOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, CHEST PAIN (Burning chest pain/sharp chest pain), BACK PAIN (Sharp back pain), PAIN (Body pain), HEADACHE (Headache), MYALGIA (Body pain) and FATIGUE (Fatigue/tiredness) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Non-significant follow-up information received on 23-JUN-2021 and contact information updated.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Burning chest pain/sharp chest pain; Sharp back pain; Body pain; Headache; Body pain; Fatigue/tiredness; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Burning chest pain/sharp chest pain), BACK PAIN (Sharp back pain), PAIN (Body pain), HEADACHE (Headache) and MYALGIA (Body pain) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Colitis. Concomitant products included MESALAZINE (LIALDA) for Colitis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), PROBIOTICS NOS, FISH OIL, INFLIXIMAB (REMICADE) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced CHEST PAIN (Burning chest pain/sharp chest pain), BACK PAIN (Sharp back pain), PAIN (Body pain), HEADACHE (Headache), MYALGIA (Body pain) and FATIGUE (Fatigue/tiredness). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at a dose of 1 dosage form and BISMUTH SUBSALICYLATE (PEPTO-BISMOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, CHEST PAIN (Burning chest pain/sharp chest pain), BACK PAIN (Sharp back pain), PAIN (Body pain), HEADACHE (Headache), MYALGIA (Body pain) and FATIGUE (Fatigue/tiredness) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Non-significant follow-up information received on 23-JUN-2021 and contact information updated.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: achy; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy) and FATIGUE (tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PAIN (achy) and FATIGUE (tired). At the time of the report, PAIN (achy) and FATIGUE (tired) outcome was unknown.            Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Feeding disorder, Gastrooesophageal reflux disease, Vaccination site bruising
Clinical narrative: vomited just once; Extreme fatigue; Acid-Reflux; Loss of appetite; Unable to keep down spicy food; Bruise feeling on left arm; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (Acid-Reflux), DECREASED APPETITE (Loss of appetite), FEEDING DISORDER (Unable to keep down spicy food), VACCINATION SITE BRUISING (Bruise feeling on left arm) and VOMITING (vomited just once) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypoglycemia, Hypertension and Thyroid disorder. Concomitant products included AMLODIPINE for Hypertension, LEVOTHYROXINE for Thyroid disorder.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruise feeling on left arm). On 28-Mar-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (Acid-Reflux), DECREASED APPETITE (Loss of appetite), FEEDING DISORDER (Unable to keep down spicy food) and FATIGUE (Extreme fatigue). On an unknown date, the patient experienced VOMITING (vomited just once). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) ongoing since an unknown date for Acid reflux (esophageal), at a dose of 1 dosage form and ALUMINIUM HYDROXIDE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM BICARBONATE (GAVISCON [ALUMINIUM HYDROXIDE;CALCIUM CARBONATE;SODIUM ALGINATE;SODIUM BICARBONATE]) ongoing since an unknown date for Acid reflux (esophageal), at a dose of 1 dosage form. On 22-Mar-2021, VACCINATION SITE BRUISING (Bruise feeling on left arm) had resolved. At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (Acid-Reflux), DECREASED APPETITE (Loss of appetite), FEEDING DISORDER (Unable to keep down spicy food), VOMITING (vomited just once) and FATIGUE (Extreme fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received on 05-AUG-2021, updated event outcome.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomited just once; Extreme fatigue; Acid-Reflux; Loss of appetite; Unable to keep down spicy food; Bruise feeling on left arm; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (Acid-Reflux), DECREASED APPETITE (Loss of appetite), FEEDING DISORDER (Unable to keep down spicy food), VACCINATION SITE BRUISING (Bruise feeling on left arm) and VOMITING (vomited just once) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypoglycemia, Hypertension and Thyroid disorder. Concomitant products included AMLODIPINE for Hypertension, LEVOTHYROXINE for Thyroid disorder.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruise feeling on left arm). On 28-Mar-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (Acid-Reflux), DECREASED APPETITE (Loss of appetite), FEEDING DISORDER (Unable to keep down spicy food) and FATIGUE (Extreme fatigue). On an unknown date, the patient experienced VOMITING (vomited just once). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) ongoing since an unknown date for Acid reflux (esophageal), at a dose of 1 dosage form and ALUMINIUM HYDROXIDE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM BICARBONATE (GAVISCON [ALUMINIUM HYDROXIDE;CALCIUM CARBONATE;SODIUM ALGINATE;SODIUM BICARBONATE]) ongoing since an unknown date for Acid reflux (esophageal), at a dose of 1 dosage form. On 22-Mar-2021, VACCINATION SITE BRUISING (Bruise feeling on left arm) had resolved. At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (Acid-Reflux), DECREASED APPETITE (Loss of appetite), FEEDING DISORDER (Unable to keep down spicy food), VOMITING (vomited just once) and FATIGUE (Extreme fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received on 05-AUG-2021, updated event outcome.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: diagnosed with COVID; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (diagnosed with COVID) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced COVID-19 (diagnosed with COVID). At the time of the report, COVID-19 (diagnosed with COVID) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD21-070732, US-MODERNATX, INC.-MOD-2021-068781 (E2B Linked Report).; Sender's Comments:  MOD21-070732:Patient mother cross linked case US-MODERNATX, INC.-MOD-2021-068781:Crossed linked